Company: BIAF
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024163
Chunk: 22

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 22
---
 20,491  
     45,785 
  
    Operating lease cost 
     39,764  
     29,916  
     79,529  
     59,831 
  
    Total lease cost 
    $101,351  
    $276,718  
    $250,440  
    $426,426 

    Cash paid for amounts included in the measurement of lease liabilities: 

    Operating cash flows from finance leases 
    $(92,975) 
    $(90,440) 
    $(193,241) 
    $(179,105)
  
    Operating cash flows from operating leases 
     (31,443) 
     (23,434) 
     (56,238) 
     (46,402)

SCHEDULE OF BALANCE SHEET INFORMATION RELATING TO LEASES

    Operating leases: 
    June 30, 2025  
    December 31, 2024 
  
    Operating lease right-of-use, assets 
    $399,879  
    $463,011 
  
    Operating lease liability, current 
    $133,239  
    $127,498 
  
    Operating lease liability, non-current 
    274,074 
    342,098 
  
    Total operating lease liabilities 
    $407,313  
    $469,596 

    Finance leases: 
    June 30, 2025  
    December 31, 2024 
  
    Finance lease right-of-use asset, gross 
    $565,030  
    $1,294,168 
  
    Accumulated amortization 
     (397,300) 
     (513,296)
  
    Finance lease right-of-use asset, net 
    $167,730  
    $780,872 
  
    Finance lease liability, current portion 
    $179,844  
    $395,301 
  
    Finance lease liability, long-term 
     3,942  
     444,448 
  
    Total finance lease liabilities 
    $183,786  
    $839,749 

    Weighted-average remaining lease term: 
    June 30, 2025  
    December 31, 2024 
  
    Operating leases (in years) 
     3.83  
     4.21 
  
    Finance leases (in years